Exhibit 107
Calculation of Filing Fee Table
S-1
(Form Type)
Kairos Pharma, Ltd.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type | Security Class Title | Fee Calculation Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | |||||||||||||||||||||
| Fees to Be Paid | Equity | Common Stock, par value $0.001 per share (1) | 457 | (o) | $ | 15,000,000 | 0.0001531 | $ | 2,297 | |||||||||||||||||||
| Fees to Be Paid | Equity | Common Stock, par value $0.001 per share (1) | 457 | (o) | $ | 900,000 | 0.0001531 | $ | 138 | |||||||||||||||||||
| Total Offering Amounts | $ | 15,900,000 | ||||||||||||||||||||||||||
| Total Fees Previously Paid | — | — | — | |||||||||||||||||||||||||
| Total Fee Offsets | — | — | — | |||||||||||||||||||||||||
| Net Fee Due | $ | 2,435 | ||||||||||||||||||||||||||
| (1) | Reflects (i) up to $10,000,000 common stock of the Company, par value $0.001 per share (the “Common Stock”) to be sold by the Company to Helena Global Investment Opportunities I Ltd, pursuant to the equity line of credit agreement, dated as of November 12, 2024 between the Company and Helena (the “ELOC Agreement”) and (ii) $900,000 shares of common stock issued to Helena as a commitment fee upon the execution of the ELOC Agreement. |